Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/04/19
End: 02/15/23
Due: 02/15/24
Phase: N/A
Priority: Normal
Start: 11/30/20
End: 11/14/22
Due: 11/14/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| AO-176 in Multiple Solid Tumor Malignancies | NCT03834948 | Arch Oncology | user2@example.com | None | 2019-02-04 | 2023-02-15 | 2024-02-15 | - | - | 2025-07-14 |
| Study of AO-176 as Monotherapy and in Combination With Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma | NCT04445701 | Arch Oncology | user2@example.com | None | 2020-11-30 | 2022-11-14 | 2023-11-14 | - | - | 2025-07-14 |